DK238089D0 - Substituerede 3-aminosydnoniminer eller farmaceutisk acceptable syreadditionssalte deraf, deres fremstilling og anvendelse - Google Patents

Substituerede 3-aminosydnoniminer eller farmaceutisk acceptable syreadditionssalte deraf, deres fremstilling og anvendelse

Info

Publication number
DK238089D0
DK238089D0 DK238089A DK238089A DK238089D0 DK 238089 D0 DK238089 D0 DK 238089D0 DK 238089 A DK238089 A DK 238089A DK 238089 A DK238089 A DK 238089A DK 238089 D0 DK238089 D0 DK 238089D0
Authority
DK
Denmark
Prior art keywords
sydnonymines
amino
substituted
preparation
acid addition
Prior art date
Application number
DK238089A
Other languages
English (en)
Other versions
DK238089A (da
Inventor
Karl Schoenafinger
Rudi Beyerle
Helmut Bohn
Melitta Just
Original Assignee
Cassella Farbwerke Mainkur Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cassella Farbwerke Mainkur Ag filed Critical Cassella Farbwerke Mainkur Ag
Publication of DK238089D0 publication Critical patent/DK238089D0/da
Publication of DK238089A publication Critical patent/DK238089A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/04—1,2,3-Oxadiazoles; Hydrogenated 1,2,3-oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK238089A 1988-06-11 1989-05-16 Substituerede 3-aminosydnoniminer eller farmaceutisk acceptable syreadditionssalte deraf, deres fremstilling og anvendelse DK238089A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3819914A DE3819914A1 (de) 1988-06-11 1988-06-11 Substituierte 3-aminosydnonimine, verfahren zu ihrer herstellung und ihre verwendung

Publications (2)

Publication Number Publication Date
DK238089D0 true DK238089D0 (da) 1989-05-16
DK238089A DK238089A (da) 1989-12-12

Family

ID=6356342

Family Applications (1)

Application Number Title Priority Date Filing Date
DK238089A DK238089A (da) 1988-06-11 1989-05-16 Substituerede 3-aminosydnoniminer eller farmaceutisk acceptable syreadditionssalte deraf, deres fremstilling og anvendelse

Country Status (8)

Country Link
EP (1) EP0346684A1 (da)
JP (1) JPH0232069A (da)
KR (1) KR910000674A (da)
DE (1) DE3819914A1 (da)
DK (1) DK238089A (da)
HU (1) HU201535B (da)
PT (1) PT90787A (da)
ZA (1) ZA894381B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3837327A1 (de) * 1988-11-03 1990-05-10 Cassella Ag Substituierte 3-aminosydnonimine, verfahren zu ihrer herstellung und ihre verwendung
DE4025604A1 (de) * 1990-08-13 1992-02-20 Cassella Ag 3-dicyclohexylamino-sydnonimine, verfahren zu ihrer herstellung und ihre verwendung
DE4028679A1 (de) * 1990-09-10 1992-03-19 Cassella Ag Substituierte 3-aminosydnonimine, verfahren zu ihrer herstellung und ihre verwendung
AU7339996A (en) * 1995-11-06 1997-05-29 Chugai Seiyaku Kabushiki Kaisha Sydnone imine derivatives

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1496056A (fr) * 1964-06-08 1967-09-29 Takeda Chemical Industries Ltd Nouveaux composés chimiques du type sydnonimine
AT275514B (de) * 1966-08-09 1969-10-27 Boehringer Sohn Ingelheim Verfahren zur Herstellung neuer substituierter 3-Amino-sydnonimine und deren Salze
FI49412C (fi) * 1967-10-23 1975-06-10 Boehringer Sohn Ingelheim Menetelmä substituoitujen 3-amino-sydnoni-imiinien valmistamiseksi.
DE3526068A1 (de) * 1985-07-20 1987-01-22 Cassella Ag Substituierte 3-amino-sydnonimine, verfahren zu ihrer herstellung, ihre verwendung und sie enthaltende pharmazeutische praeparate

Also Published As

Publication number Publication date
HUT51605A (en) 1990-05-28
PT90787A (pt) 1989-12-29
HU201535B (en) 1990-11-28
DE3819914A1 (de) 1989-12-21
EP0346684A1 (de) 1989-12-20
ZA894381B (en) 1990-02-28
DK238089A (da) 1989-12-12
JPH0232069A (ja) 1990-02-01
KR910000674A (ko) 1991-01-30

Similar Documents

Publication Publication Date Title
DK374289A (da) Indazol-3-carboxylsyrederivater, deres fremstilling og anvendelse
DK605489A (da) Beta-amino-boronsyre-derivater, deres fremstilling og anvendelse
NO892745D0 (no) Aminoalkylaminokarbonylaminodiolaminosyrederivater og fremgangsmaate for deres fremstilling.
DK519189D0 (da) Spiro-isoquinolin-pyrrolidin-tetroner eller farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse
DK266486D0 (da) Quinoloncarboxylsyreestere eller farmaceutisk anvendelige hydratereller syreadditionssalte deraf, deres fremstilling og anvendelse
NO891749D0 (no) Syreaddisjonssalter, deres fremstilling og anvendelse.
DK521986D0 (da) Benzylaminderivater eller syreadditionssalte deraf, deres fremstilling og anvendelse som fungicider
DK192788D0 (da) Substituerede anilidderivater eller syreadditionssalte deraf, deres fremstilling og anvendelse
DK333989D0 (da) N-phenylpyrazolyletherderivater og pesticidt acceptable syreadditionssalte deraf, deres fremstilling og anvendelse som pesticider
DK69389D0 (da) Renin-haemmende aminosyrederivater og fysiologisk acceptable salte deraf, deres fremstilling og anvendelse
DK144885D0 (da) Substituerede 4-hydroxybenzopyraner eller farmaceutisk acceptable additionssalte deraf, deres fremstilling og anvendelse som laegemidler
DK157387A (da) Substiturede 4-amino-3-hydroxysmoersyrederivater ogfysiologisk acceptable salte deraf, deres fremstilling og anvendelse
DK543788D0 (da) Reninhaemmende dipeptider eller fysiologisk acceptable salte deraf, deres fremstilling og anvendelse
DK238089D0 (da) Substituerede 3-aminosydnoniminer eller farmaceutisk acceptable syreadditionssalte deraf, deres fremstilling og anvendelse
DK179786D0 (da) (-)-1beta-ethyl-1alfa-hydroxylmethyl-1,2,3,4,6,7,12,12balfa-octa-hydroindolo(2,3-a)quinolizin og syreadditionssalte deraf, deres fremstilling og anvendelse som farmaceutika
DK587689D0 (da) 2-azabicyclo(2,2,1)hept-5-en-2-eddikesyre og derivater deraf, deres fremstilling og anvendelse
DK192588A (da) Pyrrolaldehyder eller farmaceutisk acceptable syreadditionssalte deraf, deres fremstilling og anvendelse
DK375689D0 (da) Isoxazolobenzoxazepiner, geometriske isomere, stereoisomere og farmaceutisk acceptable syreadditionssalte deraf, deres fremstilling og anvendelse
DK523289A (da) 2,3,5,6-tetrahydro(1,3,6)triazocino(1,2-a)benzim- idazoler eller farmaceutisk acceptable syreadditionssalte deraf og deres anvendelse
DK291986D0 (da) 10alfa-methoxy-6-methylergolinderivater eller fysiologisk acceptable syreadditionssalte deraf, deres fremstilling og anvendelse
DK404386D0 (da) Spergualinbeslaegtede forbindelser eller fysiologisk acceptable salte deraf, deres fremstilling og anvendelse
DK504386A (da) Gonadoliberinanaloge og farmaceutisk acceptable syreadditionssalte, deres fremstilling og anvendelse
DK292086A (da) 2-halogennicergolinderivater eller syreadditionssalte deraf, deres fremstilling og anvendelse
DK559388D0 (da) Anthracyclinderivater og farmaceutisk uskadelige syreadditionssalte deraf, deres fremstilling og anvendelse
DK120088A (da) Cephalosporinderivater og fysiologisk acceptable syreadditionssalte deraf, deres fremstilling og anvendelse

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment